Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.34 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11686519 | 0.97 | PPARD (0.56) | PPARDTSHRTP53TDP1ALDH1A1 | |
| Oxalic Acid SCHEMBL1161001 | 0.89 | PPARD (0.54) | PPARDTSHRTP53TDP1ALDH1A1 | |
| SCHEMBL27711689 | 0.88 | TSHR (0.48) | PPARDTSHRTP53TDP1ALDH1A1 | |
| SCHEMBL491488 | 0.85 | PPARD (0.54) | PPARDTSHRTP53TDP1MEN1 | |
| SCHEMBL9203692 | 0.83 | PPARD (0.52) | PPARDTSHRTP53TDP1MEN1 | |
| SCHEMBL3313657 | 0.83 | PPARD (0.70) | PPARDTSHRTP53TDP1MEN1 | |
| SCHEMBL29374057 | 0.81 | PPARD (0.50) | PPARDTSHRMEN1CYP1A2KMT2A | |
| SCHEMBL15927961 | 0.81 | PPARD (0.50) | PPARDTSHRMEN1CYP1A2KMT2A | |
| SCHEMBL5841645 | 0.81 | PPARD (0.50) | PPARDTSHRMEN1CYP1A2KMT2A | |
| SCHEMBL14189812 | 0.81 | PPARD (0.50) | PPARDTSHRMEN1CYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431444-A | Synthesis method of novel electron transport layer material and application of novel electron transport layer material in perovskite solar cell | 青岛大学 | 2025-02-14 | — | — | CN | claimed |
| US-20140294704-A1 | SOLVENT AND METHOD FOR REMOVAL OF AN ACID GAS FROM A FLUID STREAM | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-10-02 | — | — | US | claimed |
| US-8729089-B2 | Pyrido(3,2-d)pyrimidines useful for treating viral infections | GILEAD SCIENCES, INC. (US) | 2014-05-20 | — | — | US | claimed |
| WO-2008077651-A1 | PYRIDO(3,2-D)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2008-07-03 | — | — | WO | claimed |
| US-4022760-A | HORMONES | PARKE, DAVIS & COMPANY (US) | 1977-05-10 | — | — | US | claimed |
| US-4022761-A | HORMONES | PARKE, DAVIS & COMPANY (US) | 1977-05-10 | — | — | US | claimed |
| JP-4356496-A | — | — | None | — | — | JP | disclosed |
| US-12522685-B2 | Block copolymers with a fluorinated block and a phosphorus-containing block | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-01-13 | — | — | US | disclosed |
| US-20250367188-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250241109-A1 | Electron Transporting Self-Assembling Monolayer Compound for Use in Optoelectronic and/or Photoelectrochemical Devices and Manufacture Thereof | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2025-07-24 | — | — | US | disclosed |
| EP-4590099-A1 | ELECTRON TRANSPORTING SELF-ASSEMBLING MONOLAYER COMPOUND FOR USE IN OPTOELECTRONIC AND/OR PHOTOELECTROCHEMICAL DEVICES AND MANUFACTURE THEREOF | Kaunas University of Technology (LT) | 2025-07-23 | — | — | EP | disclosed |
| US-20250144253-A1 | 3-((3-([1,1'-BIPHENYL]-3-YLMETHOXY)PHENOXY)METHYL)BENZONITRILE DERIVATIVES AND THE USE THEREOF | HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF E.V. (DE) | 2025-05-08 | — | — | US | disclosed |
| CN-119431444-A | Synthesis method of novel electron transport layer material and application of novel electron transport layer material in perovskite solar cell | 青岛大学 | 2025-02-14 | — | — | CN | disclosed |
| US-4022760-A | HORMONES | PARKE, DAVIS & COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
| US-4022760-A | HORMONES | PARKE, DAVIS & COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
| US-4022759-A | HORMONES | PARKE, DAVIS & COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
| US-4022761-A | HORMONES | PARKE, DAVIS & COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
| US-3887353-A | Diethyl betaaminoethylphosphonate as an algaecide | GATES RUBBER CO | 1975-06-03 | — | — | US | disclosed |
| US-3887353-A | Diethyl betaaminoethylphosphonate as an algaecide | GATES RUBBER CO | 1975-06-03 | — | — | US | disclosed |
| US-3764677-A | DIETHYL BETAAMINOETHYLPHOSPHONATE AS AN ANTIMICROBIAL AGENT | GATES RUBBER CO | 1973-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144253-A1 | 3-((3-([1,1'-BIPHENYL]-3-YLMETHOXY)PHENOXY)METHYL)BENZONITRILE DERIVATIVES AND THE USE THEREOF | CYP4B1, UGT2B7, UGT1A4 | PPARD 1725/4885TSHR 2163/4885TP53 2877/4885 |
| US-20250367188-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | SLC10A1, SLC10A2, FABP3 | PPARD 18/4885TSHR 680/4885TP53 3873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.